FOL005 (Wound healing)

FOL005 has promising antifibrotic, revascularisation and angiogenic properties, which means that FOL005 also has an interesting therapeutic potential in wound healing. There is also potential in scleroderma, where fibrosis plays a central role. Preclinical studies have demonstrated this potential and Coegin Pharma is now exploring the initiation of an investigator-initiated clinical trial to test FOL005 for treatment of wounds.